Royalty Pharma RPRX
NASDAQ RPRX
$69.31 +0.34 (+0.49%)
At close: Nov 13, 2026 · 4:00 PM EST

Royalty Pharma (RPRX) Asset Writedowns and Impairment (2026)

Updated

Analysis

Royalty Pharma (RPRX) Asset Writedowns and Impairment (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Royalty Pharma 39.80 Bn 40.13 Bn -
2 Rocket Companies 38.90 Bn 27.72 Bn -
3 Orix 38.66 Bn 9.30 Bn 13.83 Bn
4 Federal National Mortgage Association Fannie Mae 26.46 Bn -16,107.65 Bn -
5 Synchrony Financial 22.47 Bn -45.15 Bn -
6 Affirm Holdings 22.07 Bn 15.11 Bn -
7 Royal Gold 21.71 Bn 20.92 Bn 402.46 Mn
8 Ares Capital 13.84 Bn 11.59 Bn -
9 Annaly Capital Management 13.83 Bn 4.86 Bn -
10 Federal Home Loan Mortgage 12.64 Bn -328.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 150.36 Mn
Mar 31, 2026 69.40 Mn
API Access

Royalty Pharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=RPRX&period=max&api_key=YOUR_API_KEY